Business Wire

Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years

“Additionally, M6-C patients in the study had a low rate of revision surgery compared to the ACDF cohort. Patients in the study will be monitored out to 10 years post-op as we continue to compile the ...
Business Wire

Orthofix M6-C Artificial Cervical Disc IDE Study Three- and Four-Year Data to be Presented at ISASS

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced preliminary three- and four-year functional ...
Yahoo Finance

ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc

WESTMINSTER, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that the first patient in the United ...
Healio

Prodisc C may be safe, effective at 24 months for symptomatic cervical disc disease

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Early composite clinical success showed similar outcomes ...